|
|
|
|
LEADER |
01210nam#a2200313#a#4500 |
001 |
OUN152288 |
003 |
OUN |
005 |
20060601105400 |
008 |
940406s1992 sz |||| ||eng d |
020 |
# |
# |
|a 9240560157
|
040 |
# |
# |
|a OUN
|
041 |
0 |
# |
|a eng
|a fre
|
080 |
# |
# |
|a 615.11:006(100)
|
080 |
# |
# |
|a 006(100):615.11
|
092 |
# |
# |
|s NU
|c 615.11:006(100)
|l I61
|
245 |
1 |
0 |
|a International nonpropietary names (INN) for pharmaceutical substances :
|b lists 1-65 of proposed INN and lists 1-31 of recommended INN = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées
|
246 |
3 |
1 |
|a Dénominations communes internationales (DCI) pour les substances pharmaceutiques
|b listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées
|
260 |
# |
# |
|a Genéve :
|b WHO,
|c 1992.
|
300 |
# |
# |
|a xlvi, 692 p. ;
|c 24 cm.
|
440 |
# |
# |
|a Cumulative list ;
|v no.8
|
650 |
# |
4 |
|a FARMACOPEA
|
650 |
# |
4 |
|a PRODUCTOS FARMACEUTICOS
|
650 |
# |
4 |
|a NORMALIZACION
|
650 |
# |
4 |
|a DENOMINACION COMUN INTERNACIONAL
|
866 |
0 |
# |
|a 1 ej.
|
907 |
# |
# |
|a NORMA
|
930 |
# |
# |
|a 93362
|p v
|
942 |
# |
# |
|c IMP
|
952 |
# |
# |
|p OUN93362
|a OUN
|b OUN
|o NU 615.11:006(100) I61
|y IMP
|